Business
The Resonance Health (ASX:RHT) share price has rocketed up 9% today. Here’s why.
The Resonance Health Limited (ASX: RHT) share price is soaring today after the company announced an agreement involving its flagship artificial intelligence (AI) device.
The Resonance Health share price has surged up 9.3% to trade at 23.5 cents at the time of writing.
What’s the deal?
In today’s release, Resonance Health advised that its HepaFat-AI device, which assesses fatty-liver using AI, was being incorporated into its Blackford Analysis Agreement.
The news comes as HepaFat-AI recently received regulatory clearance from the US food and drug administration (FDA) allowing Resonance to commercially sell its flagship product in the US.
Blackford delivers platforms and services for the use of medical imaging applications and AI…
-
General12 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General15 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
General13 hours agoGold Coast and Noosa councils scammed out of ratepayers’ money
-
Business15 hours agoI was a huge fan of Fortescue shares, then this happened…
